PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsMk0518
Mk0518
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
332 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv infectionsD015658EFO_0000764B202947604865236
HivD006678O98.711810232272
Acquired immunodeficiency syndromeD000163EFO_0000765B2041214111654
InfectionsD007239EFO_0000544691341343
Communicable diseasesD0031414482824
Hepatitis cD006526B19.26435117
Immunologic deficiency syndromesD007153D84.91553315
HepatitisD006505K75.95434115
Healthy volunteers/patients82212
Hepatitis aD006506EFO_0007305B153332110
Show 24 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ViremiaD014766B34.91113
Liver cirrhosisD008103EFO_0001422K74.01213
FibrosisD0053551213
Virus diseasesD014777B341213
PregnancyD011247EFO_0002950Z33.12113
Renal insufficiencyD051437N19112
Chronic hepatitisD006521K73.9111
Chronic renal insufficiencyD051436N1811
Treatment-resistant depressive disorderD06121811
HyperlipidemiasD006949EFO_0003774E78.511
Show 2 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Adult t-cell leukemia-lymphomaD015459C91.5122
T-cell leukemiaD015458122
Highly active antiretroviral therapyD023241112
LipodystrophyD008060E88.1112
LeukemiaD007938C95111
LymphomaD008223C85.9111
Liver diseasesD008107EFO_0001421K70-K77111
End stage liver diseaseD058625EFO_1001311K72.1111
Liver failureD017093K72.9111
Biliary liver cirrhosisD008105K74.311
Show 5 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DepressionD003863F33.9213
Htlv-i infectionsD015490EFO_000731622
HepacivirusD01617411
Head and neck neoplasmsD00625811
Squamous cell carcinomaD00229411
Insulin resistanceD007333EFO_0002614E88.81911
Muscle spasticityD00912811
Tropical spastic paraparesisD015493EFO_0007527G04.111
ParaparesisD020335G82.211
Spastic paraparesisD02033611
Show 4 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic hepatitis bD019694EFO_0004239B18.111
Female genital diseasesD005831EFO_0009549N8511
Genital diseasesD00009166211
Neurotoxicity syndromesD020258G9211
Sleep wake disordersD012893G4711
Liver transplantationD016031EFO_001068211
MorbidityD00901711
Organ transplantationD01637711
ProteinuriaD011507R8011
Hemophilia aD006467EFO_0007267D6611
Show 5 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
42 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use